{"log_id": 7270784982846624186, "direction": 0, "words_result_num": 51, "words_result": [{"probability": {"variance": 0.029391, "average": 0.858752, "min": 0.409423}, "location": {"width": 983, "top": 358, "height": 57, "left": 386}, "words": "天(N-1012安把剂(N=5组每日分2次给药,进行18同钓疗周用内《6周的遥量"}, {"probability": {"variance": 0.016933, "average": 0.922363, "min": 0.557467}, "location": {"width": 994, "top": 404, "height": 54, "left": 384}, "words": "加药期+12周的评期)的疗效评佑,试验可同服抗海药治疗方案保持不变。主要的"}, {"probability": {"variance": 0.031145, "average": 0.83485, "min": 0.461473}, "location": {"width": 989, "top": 448, "height": 57, "left": 386}, "words": "疗效鲁标行整个随治疗断段(逑量药价段+评价阶〕相对于安慰剂组每周部分性发"}, {"probability": {"variance": 0.027411, "average": 0.87998, "min": 0.352103}, "location": {"width": 987, "top": 491, "height": 57, "left": 388}, "words": "作频度下降百分比的间比仪,次的效指包括有效应率《部分性发作频度下降>50%"}, {"probability": {"variance": 0.030752, "average": 0.860924, "min": 0.366724}, "location": {"width": 989, "top": 537, "height": 54, "left": 388}, "words": "的病人发生率)结果派示:左乙坦治疗每周部分性发师明显地减少,整个随"}, {"probability": {"variance": 0.040536, "average": 0.826251, "min": 0.353585}, "location": {"width": 877, "top": 583, "height": 52, "left": 388}, "words": "治疗左乙拉西治疗组的有效应答是高于安慰剂组:并至制量相关性"}, {"probability": {"variance": 1.8e-05, "average": 0.990952, "min": 0.985399}, "location": {"width": 100, "top": 637, "height": 32, "left": 724}, "words": "安慰剂"}, {"probability": {"variance": 0.000313, "average": 0.980324, "min": 0.949578}, "location": {"width": 128, "top": 633, "height": 32, "left": 946}, "words": "左乙拉西坦"}, {"probability": {"variance": 0.066153, "average": 0.760044, "min": 0.418559}, "location": {"width": 125, "top": 628, "height": 34, "left": 1202}, "words": "乙拉西地"}, {"probability": {"variance": 0.001395, "average": 0.939767, "min": 0.889941}, "location": {"width": 73, "top": 685, "height": 25, "left": 743}, "words": "N=95"}, {"probability": {"variance": 0.044996, "average": 0.702914, "min": 0.395127}, "location": {"width": 112, "top": 681, "height": 29, "left": 955}, "words": "g/天"}, {"probability": {"variance": 0, "average": 0.606509, "min": 0.606509}, "location": {"width": 82, "top": 674, "height": 29, "left": 1243}, "words": " Omu"}, {"probability": {"variance": 0.010594, "average": 0.915173, "min": 0.717637}, "location": {"width": 70, "top": 727, "height": 25, "left": 983}, "words": "N=97)"}, {"probability": {"variance": 0.025386, "average": 0.893196, "min": 0.53989}, "location": {"width": 105, "top": 720, "height": 32, "left": 1214}, "words": "N=101)"}, {"probability": {"variance": 0.009106, "average": 0.913823, "min": 0.735889}, "location": {"width": 246, "top": 775, "height": 36, "left": 397}, "words": "相对于安慰剂组部分性"}, {"probability": {"variance": 0.029365, "average": 0.838364, "min": 0.564744}, "location": {"width": 61, "top": 772, "height": 27, "left": 978}, "words": "Z6.1"}, {"probability": {"variance": 0.037017, "average": 0.894172, "min": 0.510028}, "location": {"width": 66, "top": 765, "height": 29, "left": 1230}, "words": "30.1%"}, {"probability": {"variance": 0.038988, "average": 0.890505, "min": 0.38268}, "location": {"width": 230, "top": 818, "height": 38, "left": 393}, "words": "发作度下百分比"}, {"probability": {"variance": 0.060307, "average": 0.721964, "min": 0.359192}, "location": {"width": 96, "top": 873, "height": 27, "left": 400}, "words": "P0.01"}, {"probability": {"variance": 0.0281, "average": 0.90558, "min": 0.570879}, "location": {"width": 123, "top": 912, "height": 29, "left": 397}, "words": "临店研究2"}, {"probability": {"variance": 0.035152, "average": 0.854315, "min": 0.396451}, "location": {"width": 941, "top": 935, "height": 57, "left": 445}, "words": "临研么欧62个研究中心进行的双、安慰剂对照的交里试验,设计试验生"}, {"probability": {"variance": 0.024622, "average": 0.90012, "min": 0.367824}, "location": {"width": 985, "top": 980, "height": 52, "left": 395}, "words": "第一段(阶段A)作为平行试验米分析,在12同的基线阶段后:病人随机分入左乙"}, {"probability": {"variance": 0.059753, "average": 0.71885, "min": 0.35289}, "location": {"width": 983, "top": 1024, "height": 57, "left": 395}, "words": "西100m(C6),左西2Hng天(N【Q5安慰剂组(N=111)组"}, {"probability": {"variance": 0.028842, "average": 0.895674, "min": 0.427301}, "location": {"width": 996, "top": 1067, "height": 54, "left": 397}, "words": "每日分2次给药进行了15周的治疗周(拿的逐量加药指和12周的稳定剂量评价阶"}, {"probability": {"variance": 0.028567, "average": 0.894624, "min": 0.434622}, "location": {"width": 996, "top": 1111, "height": 59, "left": 397}, "words": "段了的疗效评估,在试验步服抗痫查的治疗方案保持不变。主要的疗效指标在整个随"}, {"probability": {"variance": 0.035762, "average": 0.848453, "min": 0.360423}, "location": {"width": 996, "top": 1156, "height": 59, "left": 395}, "words": "机治疗阶段(量湘药期中评价阶段】对于安慰剂组每部分发作频度下降百分比的"}, {"probability": {"variance": 0.042239, "average": 0.837243, "min": 0.358856}, "location": {"width": 987, "top": 1200, "height": 61, "left": 404}, "words": "川比仪,饮要的疗效指标包括有效应答率(分蚀发作频度下降20%的病人发生卓,结"}, {"probability": {"variance": 0.032944, "average": 0.889218, "min": 0.372295}, "location": {"width": 994, "top": 1243, "height": 61, "left": 402}, "words": "显示:左乙拉西坦治疗租每周部分发作频度有明显地减少整个随机治疗价段乙拉西"}, {"probability": {"variance": 0.057634, "average": 0.75821, "min": 0.365863}, "location": {"width": 989, "top": 1289, "height": 61, "left": 402}, "words": "疗的响效答密显高于安别红并剂最关性拉西2mg天对左乙"}, {"probability": {"variance": 0.042943, "average": 0.80418, "min": 0.388509}, "location": {"width": 996, "top": 1335, "height": 57, "left": 402}, "words": "北西:0mg/天有效应等率的比较县统录性(P=0.02)、对交叉试的了"}, {"probability": {"variance": 0.008245, "average": 0.937093, "min": 0.780076}, "location": {"width": 102, "top": 1401, "height": 29, "left": 404}, "words": "似的结果"}, {"probability": {"variance": 0.016523, "average": 0.789161, "min": 0.677114}, "location": {"width": 96, "top": 1438, "height": 32, "left": 738}, "words": "安慰剂组"}, {"probability": {"variance": 0.019624, "average": 0.853357, "min": 0.617676}, "location": {"width": 130, "top": 1431, "height": 32, "left": 964}, "words": "左乙拉西坦"}, {"probability": {"variance": 0.056806, "average": 0.753323, "min": 0.406034}, "location": {"width": 148, "top": 1422, "height": 36, "left": 1200}, "words": "乙拉西姐"}, {"probability": {"variance": 0.001939, "average": 0.926337, "min": 0.854219}, "location": {"width": 89, "top": 1486, "height": 25, "left": 745}, "words": "(N-111"}, {"probability": {"variance": 0.019916, "average": 0.835446, "min": 0.598433}, "location": {"width": 114, "top": 1474, "height": 34, "left": 976}, "words": "Comg/天"}, {"probability": {"variance": 0.059219, "average": 0.619721, "min": 0.354371}, "location": {"width": 150, "top": 1465, "height": 36, "left": 1191}, "words": "H00m天"}, {"probability": {"variance": 0.041601, "average": 0.884932, "min": 0.477256}, "location": {"width": 93, "top": 1522, "height": 27, "left": 985}, "words": "N=]06"}, {"probability": {"variance": 0.000195, "average": 0.982483, "min": 0.9567}, "location": {"width": 123, "top": 1511, "height": 36, "left": 1198}, "words": "N=105"}, {"probability": {"variance": 0.030944, "average": 0.72766, "min": 0.454798}, "location": {"width": 256, "top": 1575, "height": 34, "left": 406}, "words": "相对一安慰剂组部分性"}, {"probability": {"variance": 0.027105, "average": 0.804149, "min": 0.594588}, "location": {"width": 57, "top": 1570, "height": 25, "left": 1001}, "words": "71%"}, {"probability": {"variance": 0.023383, "average": 0.873116, "min": 0.575782}, "location": {"width": 230, "top": 1620, "height": 36, "left": 406}, "words": "发作频度下降百分比"}, {"probability": {"variance": 0.017252, "average": 0.813635, "min": 0.607477}, "location": {"width": 73, "top": 1673, "height": 25, "left": 416}, "words": "<0.00"}, {"probability": {"variance": 0.00041, "average": 0.980948, "min": 0.944171}, "location": {"width": 130, "top": 1712, "height": 32, "left": 406}, "words": "临床研究3"}, {"probability": {"variance": 0.023223, "average": 0.886985, "min": 0.466501}, "location": {"width": 946, "top": 1730, "height": 61, "left": 459}, "words": "深究3是在欧洲47个研究中心进行的双育。安慰剂对源的平行组大验,研究比"}, {"probability": {"variance": 0.027955, "average": 0.868054, "min": 0.386652}, "location": {"width": 992, "top": 1776, "height": 61, "left": 411}, "words": "较了对伴或不什有发性全身发作的治性部分发作病人,仅同一种狗药治疗"}, {"probability": {"variance": 0.016356, "average": 0.936354, "min": 0.418627}, "location": {"width": 713, "top": 1829, "height": 52, "left": 416}, "words": "12周的基线阶段后,人随机分配入的述2个治疗中的一个"}, {"probability": {"variance": 0, "average": 0.97212, "min": 0.97212}, "location": {"width": 116, "top": 1822, "height": 32, "left": 1287}, "words": "个"}, {"probability": {"variance": 0.039217, "average": 0.851421, "min": 0.430288}, "location": {"width": 960, "top": 1863, "height": 66, "left": 409}, "words": "牛周重加药段:在12周的定剂阶段进行了疗效的骨法要的打妆指标指"}, {"probability": {"variance": 0.043233, "average": 0.82664, "min": 0.369247}, "location": {"width": 996, "top": 1909, "height": 64, "left": 413}, "words": "个治疗阶段(逐量药评价阶段】相对于安方组每周部分度下降百的组"}, {"probability": {"variance": 0.03118, "average": 0.87167, "min": 0.451854}, "location": {"width": 951, "top": 1954, "height": 61, "left": 413}, "words": "间化较。次要的疗效指标包括有效应答率《部分性发作频度下降钓病人发生率"}], "language": 3}